Cormorant Asset Management, LP Precision Biosciences Inc Transaction History

Cormorant Asset Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.15 - $3.34 $398,502 - $1.16 Million	-346,524 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$5.05 - $15.01 $611,009 - $1.82 Million	-120,992 Reduced 25.88%	346,524 $2.09 Million
Q4 2019 Feb 14, 2020	SELL	$6.32 - $19.66 $12 - $39	-2 Reduced -0.0%	467,516 $6.49 Million
Q2 2019 Aug 14, 2019	SELL	$11.88 - $16.94 $3.71 Million - $5.29 Million	-312,500 Reduced 40.06%	467,518 $6.2 Million
Q1 2019 May 15, 2019	BUY	$17.44 - $17.95 $13.6 Million - $14 Million	780,018 New	780,018 $14 Million

2.56M

Ticker DTIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 110,818,000
Market Cap $842M
Description
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...

Get notified when there are updates to the investment portfolio of Cormorant Asset Management, LP, based on Form 13F filings with the SEC.

Stay updated on Cormorant Asset Management, LP with notifications on news.